A Review and Assessment of EU Drug Policy

28-11-2016

This study, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of the LIBE Committee, provides an overview of the drug policies in international fora, at EU level, in seven Member States and in three non-EU countries. The study highlights the very different approaches taken and their varying level of effectiveness.

This study, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of the LIBE Committee, provides an overview of the drug policies in international fora, at EU level, in seven Member States and in three non-EU countries. The study highlights the very different approaches taken and their varying level of effectiveness.

    Studio pdf  
Autore esterno

Mirja GUTHEIL, Quentin LIGER, Aurelie HEETMAN, James EAGER and Solveig BOURGEON (Optimity Advisors)